Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis
This study has been completed.
Study NCT00638456   Information provided by University of California, San Diego
First Received: March 12, 2008   Last Updated: September 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Eosinophilic Esophagitis
Additional conditions recognized in this trial
Esophagitis
More general conditions related to this trial
Digestive System Diseases
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Interventions listed in this trial
Budesonide plus Prevacid
placebo plus Prevacid
Additional drug interventions recognized in this trial
Budesonide
Lansoprazole
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Ulcer Agents
Autonomic Agents
Bronchodilator Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of California, San Diego
Meritage Pharma, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services